We show that R273 mutations direct a unique transcriptional program, which is not expressed in p53-null CRC cells or in tumors harboring truncating TP53 mutations, and thus constitutes a GOF activity of R273 mutants. The gene discussed is TP53; the disease is colorectal carcinoma.